Lancet Reg Health Eur. 2022 Mar 22;15:100344. doi: 10.1016/j.lanepe.2022.100344. eCollection 2022 Apr.
NO ABSTRACT
PMID:35342893 | PMC:PMC8943426 | DOI:10.1016/j.lanepe.2022.100344
Categories
Concerns about the external validity of the study ‘prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study’-authors´ reply
